📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009. (2013)

First Author: Abgrall S

Attributed to: Prognosis of HIV-positive patients treated with antiretroviral therapy: comparative analyses and treatment strategies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0b013e32835cb997

PubMed Identifier: 23719350

Publication URI: http://europepmc.org/abstract/MED/23719350

Type: Journal Article/Review

Volume: 27

Parent Publication: AIDS (London, England)

Issue: 5

ISSN: 0269-9370